G859-0155 Screening compound: 2-{[(2-chlorophenyl)methyl]sulfanyl}-3-(3,5-dimethylphenyl)-7-(morpholine-4-carbonyl)-3,4-dihydroquinazolin-4-one

G859-0155 Screening compound: 2-{[(2-chlorophenyl)methyl]sulfanyl}-3-(3,5-dimethylphenyl)-7-(morpholine-4-carbonyl)-3,4-dihydroquinazolin-4-one
G859-0155 Screening compound: 2-{[(2-chlorophenyl)methyl]sulfanyl}-3-(3,5-dimethylphenyl)-7-(morpholine-4-carbonyl)-3,4-dihydroquinazolin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G859-0155
2-{[(2-chlorophenyl)methyl]sulfanyl}-3-(3,5-dimethylphenyl)-7-(morpholine-4-carbonyl)-3,4-dihydroquinazolin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G859-0155

Molecular Formula

C28H26ClN3O3S (C28 H26 ClN3 O3 S)

Compound Name

2-{[(2-chlorophenyl)methyl]sulfanyl}-3-(3,5-dimethylphenyl)-7-(morpholine-4-carbonyl)-3,4-dihydroquinazolin-4-one

IUPAC name

2-{[(2-chlorophenyl)methyl]sulfanyl}-3-(35-dimethylphenyl)-7-(morpholine-4-carbonyl)-34-dihydroquinazolin-4-one

SMILES

Cc1cc(N2C(SCc(cccc3)c3Cl)=Nc(cc(cc3)C(N4CCOCC4)=O)c3C2=O)cc(C)c1

InChI

InChI=1S/C28H26ClN3O3S/c1-18-13-19(2)15-22(14-18)32-27(34)23-8-7-20(26(33)31-9-11-35-12-10-31)16-25(23)30-28(32)36-17-21-5-3-4-6-24(21)29/h3-8,13-16H,9-12,17H2,1-2H3

InChI Key

PDPSZRVAMDUVGT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15041966

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

520.05

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.861

Distribution Coefficient, logD

4.858

Water Solubility, LogSw

-4.82

Polar Surface Area

49.716

Acid Dissociation Constant (pKa)

28.80

Base Dissociation Constant (pKb)

5.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

G859-0155 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

CNS Targets (44014 compounds)

PI3K-Targeted Library (17255 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with G859-0155 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G859-0155?
Check Price and Availability of G859-0155, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G859-0155 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G859-0155
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G859-0155
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G859-0155 available by request